Analyst Ratings for Medtronic, Inc. (MDT)
MDT Rating Summary
MDT Price Target Summary
- Highest: $51.00 (Deutsche Bank)
- Lowest: $36.00 (Goldman Sachs)
- Average: $45.20
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$45.20 (-9.3%)
Avg. $ Target:
$45.20 (-9.3%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/16/2013 | Credit Suisse | Downgrade | Neutral (Outperform) |
N/A (N/A) |
50.01 | 49.84 | -0.34% | Details |
| 4/12/2013 | Deutsche Bank | Upgrade | Hold (N/A) |
51.00 (46.00) |
47.72 | 49.84 | 4.44% | Details |
| 2/14/2013 | Lazard Capital | Downgrade | Neutral (Buy) |
N/A (N/A) |
46.99 | 49.84 | 6.07% | Details |
| 1/25/2013 | Wunderlich Securities | Downgrade | Hold (Buy) |
46.00 (46.00) |
46.45 | 49.84 | 7.3% | Details |
| 1/3/2013 | Mizuho Securities | Upgrade | Buy (Neutral) |
N/A (N/A) |
41.88 | 49.84 | 19.01% | Details |
| 11/20/2012 | Stifel Nicolaus | New Coverage | Hold (N/A) |
N/A (N/A) |
41.81 | 49.84 | 19.21% | Details |
| 8/17/2012 | Argus | Upgrade | Buy (Sell) |
N/A (N/A) |
40.47 | 49.84 | 23.15% | Details |
| 3/2/2012 | Northland Securities » Updated 11/21/2012 |
New Coverage | Market Perform (N/A) |
46.00 (44.00) |
38.00 | 49.84 | 31.16% | Details |
| 1/17/2012 | Wells Fargo | Upgrade | Outperform (N/A) |
45.00 (N/A) |
38.65 | 49.84 | 28.95% | Details |
| 12/20/2011 | Susquehanna | New Coverage | Neutral (N/A) |
40.00 (N/A) |
35.10 | 49.84 | 41.99% | Details |
| 12/5/2011 | Standpoint Research | Downgrade | Hold (N/A) |
N/A (N/A) |
34.61 | 49.84 | 44% | Details |
| 11/23/2011 | BofA/Merrill Lynch | Upgrade | Buy (N/A) |
N/A (N/A) |
33.27 | 49.84 | 49.8% | Details |
| 10/18/2011 | Cowen | New Coverage | Neutral (N/A) |
N/A (N/A) |
32.45 | 49.84 | 53.59% | Details |
| 8/9/2011 | Goldman Sachs » Updated 10/21/2011 |
Downgrade | Neutral (N/A) |
36.00 (N/A) |
33.31 | 49.84 | 49.62% | Details |
| 7/18/2011 | Barclays » Updated 8/22/2012 |
Downgrade | Equalweight (N/A) |
45.00 (41.00) |
37.12 | 49.84 | 34.27% | Details |
